188 related articles for article (PubMed ID: 36994064)
21. COVID-19 Associated Mucormycosis with Newly Diagnosed Diabetes Mellitus in Young Males - A Tertiary Care Experience.
Kapoor S; Saidha PK; Gupta A; Saini U; Satya S
Int Arch Otorhinolaryngol; 2022 Jul; 26(3):e470-e477. PubMed ID: 35846801
[No Abstract] [Full Text] [Related]
22. Clinical Profile of Patients Admitted With Mucormycosis During the COVID-19 Pandemic in Medicine Emergency of a Tertiary Care Hospital in North India.
Singla N; Sharma N; Sharma N; Behera A; Bhatia M
Cureus; 2022 Sep; 14(9):e29219. PubMed ID: 36159346
[TBL] [Abstract][Full Text] [Related]
23. Diabetes and rhino-orbito-cerebral mucormycosis - A deadly duo.
Singh P; Arora S; Mittal N; Singh A; Verma R; Sharma S; Agrawal NK; Goyal S
J Diabetes Metab Disord; 2021 Jun; 20(1):201-207. PubMed ID: 34222064
[TBL] [Abstract][Full Text] [Related]
24. The mucormycosis and stroke: The learning curve during the second COVID-19 pandemic.
Ramachandran D; R A; Panicker P; S J; Sathyabhama MC; Nair A; Chandran RS; George S; S C; Iype T
J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106819. PubMed ID: 36495645
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 Associated Mucormycosis (CAM): A Single Hospital-Based Study.
Vijapur MM; Kattimani V; Varsha VK; Girish HC; Kamat M; Ram B
J Oral Maxillofac Pathol; 2022; 26(2):147-155. PubMed ID: 35968169
[TBL] [Abstract][Full Text] [Related]
26. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
Wasiq M; K R; Gn A
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
[TBL] [Abstract][Full Text] [Related]
27. Rhino-orbito-cerebral mucormycosis: patient characteristics in pre-COVID-19 and COVID-19 period.
Cherian LM; Varghese L; Rupa V; Bright RR; Abraham L; Panicker R; R N; Peter J; Nayak A; Shyam A; Varghese GM; Manesh A; Karuppusami R; George K; George T; Lenin A; Hansdak SG; I R; Michael JS; Ninan M; Thomas M; Kurian R; Mammen S; Kurien R
Rhinology; 2022 Dec; 60(6):427-434. PubMed ID: 36150158
[TBL] [Abstract][Full Text] [Related]
28. Clinical features, diagnosis, and outcomes of rhino-orbito-cerebral mucormycosis- A retrospective analysis.
Abdollahi A; Shokohi T; Amirrajab N; Poormosa R; Kasiri AM; Motahari SJ; Ghoreyshi SM; Madani SA; Nikkhah M; Ghasemi M; Vahedi Larijani L; Didehdar M; Seifi Z; Gholinejad N; Ilkit M
Curr Med Mycol; 2016 Dec; 2(4):15-23. PubMed ID: 28959791
[TBL] [Abstract][Full Text] [Related]
29. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology, Clinical Profile, and Analysis of Risk Factors in COVID Associated Rhino-orbito-cerebral Mucormycosis Patients - An Observational Study.
Jog K; Nazirudeen R; Eagappan S; Santharam RK; Sridhar S
Indian J Endocrinol Metab; 2023; 27(6):519-523. PubMed ID: 38371190
[TBL] [Abstract][Full Text] [Related]
31. Surgical management of post-COVID invasive rhino-orbito-cerebral mucormycosis and its outcomes: Role of neurosurgeons in a tertiary care center.
Das AK; Mani SK; Singh SK
Surg Neurol Int; 2022; 13():335. PubMed ID: 36128146
[TBL] [Abstract][Full Text] [Related]
32. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital.
Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM
Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754
[TBL] [Abstract][Full Text] [Related]
33. A clinico-pathological study of COVID-19 associated rhino-orbital-cerebral mucormycosis.
Mani S; Thirunavukkarasu A
Indian J Ophthalmol; 2022 Mar; 70(3):1013-1018. PubMed ID: 35225563
[TBL] [Abstract][Full Text] [Related]
34. Rhino-Orbito-Cerebral Mucormycosis During the Second Wave of Covid-19: The Indian Scenario.
Bhardwaj R; Sharma A; Parasher A; Gupta H; Sahu S; Pal S
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3492-3497. PubMed ID: 34786356
[TBL] [Abstract][Full Text] [Related]
35. Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review.
Almyroudi MP; Akinosoglou K; Rello J; Blot S; Dimopoulos G
Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553099
[TBL] [Abstract][Full Text] [Related]
36. Clinical Profile of Central Nervous System Involvement in Patients with Rhino Orbital Cerebral Mucormycosis.
Yadav S; Bs N; Ak S
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443423
[TBL] [Abstract][Full Text] [Related]
37. The Study of Clinical Profile of Patients With Mucormycosis During COVID-19 Pandemic in Tertiary Care Hospital.
Kumar S; Anita ; Dev A; Kumar A; Kumar Nayan S; Singh S
Cureus; 2023 Oct; 15(10):e47065. PubMed ID: 38021649
[TBL] [Abstract][Full Text] [Related]
38. Neuro-mucormycosis: Lessons from COVID-19-associated cases.
Sedaghat N; Etemadifar M; Ghasemi P; Naghizadeh M; Mokari Y; Salari M; Golastani B
Curr J Neurol; 2023 Oct; 22(4):255-260. PubMed ID: 38425352
[No Abstract] [Full Text] [Related]
39. Cerebrovascular Involvement in Mucormycosis in COVID-19 Pandemic.
Kulkarni R; Pujari SS; Gupta D; Ojha P; Dhamne M; Bolegave V; Dhonde P; Soni A; Adwani S; Diwan A; Duberkar D; Batra D; Deshpande R; Aurangabadkar K; Palasdeokar N
J Stroke Cerebrovasc Dis; 2022 Feb; 31(2):106231. PubMed ID: 34890962
[TBL] [Abstract][Full Text] [Related]
40. Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study.
Reddy YM; Yeduguri S; Reddy N VS; Parida S; Kamatham SN; Pidaparthi L; Jaiswal SK; Sadhvani B; Tourani V; Kumar S; Challa S; Murthy JM
J Mycol Med; 2022 May; 32(2):101252. PubMed ID: 35134736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
